EHA Takes Early Action on EU’s Forthcoming Biotech Act: Biotechnology Wonders 2026
The European Hematology Association (EHA) recently shared a post on X:
”The EU is developing new legislation that will impact hematology – the Biotech Act.
EHA ensures that hematologists are represented in this process.”
Read the preliminary recommendations for a Biotech Act here.
In 2024, the European Commission launched preparatory work on a landmark piece of legislation—the Biotech Act—set to be formally proposed in 2026.
Aimed at streamlining the development and market access of biotech products, the regulation also seeks to uphold high safety standards while bolstering the competitiveness and scale of the EU’s biotechnology sector.
Although the legislative text is still in the works, key stakeholders are already mobilizing.
The European Hematology Association (EHA) has actively stepped in to ensure the voice of hematologists is heard from the outset.
Through early advocacy and strategic engagement, EHA is positioning the hematology community to help shape a regulatory environment that supports innovation while protecting patient safety.
As the Biotech Act progresses, EHA remains committed to representing the field throughout every phase of the EU legislative process.
Latest updates in the World of Hematology featured in Hemostasis Today.
-
Jan 14, 2026, 11:26Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
-
Jan 14, 2026, 11:16ISTH 2026: Laurent Bertoletti To Serve as Vice Theme Leader for VTE
-
Jan 14, 2026, 11:08Leni von Bonsdorff Invites You to Hear and Learn The Latest News in The Plasma Field
-
Jan 14, 2026, 05:56Arun V J on The “Whole Blood” Nostalgia Trap
-
Jan 13, 2026, 16:38Caitlin Raymond: Understanding TAMOF as a TTP-Like Process
-
Jan 13, 2026, 15:22John Amako: Childhood to Adulthood Management Approach for SCD
-
Jan 13, 2026, 13:03Claudio Laudani on Dual Versus Single Antiplatelet Therapy
-
Jan 13, 2026, 12:46Stephanie Carlin and Colleagues on Clinical Outcomes of DOAC-Anticonvulsant Coprescription
-
Jan 13, 2026, 10:53Lena Volland on Ming Y Lim’s Example of Designing Care Models for WGBD Community With Intention